- Investing Ideas
- Vietnamese Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Vietnamese Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Results
4
1 new
Value score of at least 4 focused on companies with a low market cap.
4 companies
Central Pharmaceutical No3
Market Cap: ₫1.3t
Engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally.
DP3
₫58,600.00
7D
0.9%
1Y
9.5%
SPM
Market Cap: ₫129.4b
Manufactures and sells pharmaceutical products in Vietnam.
SPM
₫9,400.00
7D
6.6%
1Y
-17.9%
Phong Phu Pharmaceutical
Market Cap: ₫159.3b
Engages in the production, sale, and distribution of medicines primarily in Vietnam.
New
PPP
₫18,100.00
7D
-2.7%
1Y
-16.6%
Cai Lay Veterinary Pharmaceutical
Market Cap: ₫88.5b
Produces and trades in veterinary medicines in Vietnam and Indochina.
MKV
₫17,700.00
7D
0%
1Y
90.3%